D-glutamate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
380 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Major depressive disorder | D003865 | EFO_0003761 | F22 | 6 | 6 | 3 | 1 | 12 | 28 |
| Depression | D003863 | — | F33.9 | 6 | 6 | 3 | 2 | 5 | 21 |
| Schizophrenia | D012559 | EFO_0000692 | F20 | 3 | 5 | 3 | 4 | 3 | 18 |
| Bipolar disorder | D001714 | EFO_0000289 | F30.9 | 2 | 4 | 1 | 2 | 5 | 14 |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | 3 | 3 | — | 2 | 3 | 11 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 2 | 7 | — | 1 | 1 | 9 |
| Psychotic disorders | D011618 | — | F20.81 | 1 | 1 | — | 2 | 2 | 6 |
| Cocaine-related disorders | D019970 | — | F14 | 2 | 1 | — | 1 | 1 | 5 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | — | — | — | 1 | 2 | 3 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | 2 | — | 2 |
Show 18 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 3 | 14 | 6 | — | 1 | 22 |
| Healthy volunteers/patients | — | — | — | 13 | 5 | 1 | — | 4 | 21 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | 6 | 3 | — | 1 | 10 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 6 | 2 | — | 1 | 9 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 3 | 3 | 1 | — | — | 6 |
| Treatment-resistant depressive disorder | D061218 | — | — | 3 | 2 | 1 | — | — | 6 |
| Epilepsy | D004827 | EFO_0000474 | G40.9 | 1 | 1 | 1 | — | 4 | 6 |
| Attention deficit disorder with hyperactivity | D001289 | EFO_0003888 | F90 | 1 | 2 | 1 | — | 2 | 5 |
| Malignant mesothelioma | D000086002 | — | — | 3 | 2 | 1 | — | — | 4 |
| Fallopian tube neoplasms | D005185 | — | — | 2 | 1 | 1 | — | — | 4 |
Show 33 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obsessive-compulsive disorder | D009771 | EFO_0004242 | F42 | 1 | 8 | — | — | 3 | 11 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 6 | 7 | — | — | — | 8 |
| Triple negative breast neoplasms | D064726 | — | — | 2 | 4 | — | — | — | 4 |
| Traumatic brain injuries | D000070642 | — | S06 | 3 | 1 | — | — | — | 4 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 2 | — | — | 2 | 4 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | 2 | 4 |
| Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | 1 | 3 |
| Adenocarcinoma of lung | D000077192 | — | — | 1 | 1 | — | — | 1 | 3 |
| Autistic disorder | D001321 | HP_0000717 | F84.0 | 1 | 1 | — | — | 1 | 3 |
| Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | 1 | 1 | — | — | 1 | 3 |
Show 55 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | 2 | 3 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | 1 | 2 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | — | — | 1 | 2 |
| Positron-emission tomography | D049268 | — | — | 1 | — | — | — | 1 | 2 |
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
| Severe acute respiratory syndrome-related coronavirus | D045473 | NCBITaxon_227859 | — | 2 | — | — | — | — | 2 |
| Cigarette smoking | D000073865 | — | — | 1 | — | — | — | 1 | 2 |
| Consciousness disorders | D003244 | — | — | 1 | — | — | — | — | 1 |
| Osteosarcoma | D012516 | — | — | 1 | — | — | — | — | 1 |
| Cystadenocarcinoma | D003536 | — | — | 1 | — | — | — | — | 1 |
Show 8 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Burns | D002056 | — | T30.0 | — | — | — | — | 5 | 5 |
| Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 2 | 2 |
| Nervous system diseases | D009422 | — | G00-G99 | — | — | — | — | 2 | 2 |
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | — | — | — | 2 | 2 |
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | — | — | — | 2 | 2 |
| Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | — | — | — | — | 2 | 2 |
| Amyotrophic lateral sclerosis | D000690 | HP_0007354 | G12.21 | — | — | — | — | 2 | 2 |
| Restless legs syndrome | D012148 | EFO_0004270 | G25.81 | — | — | — | — | 2 | 2 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | — | — | — | 1 | 1 |
| Hemolysis | D006461 | — | — | — | — | — | — | 1 | 1 |
Show 51 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 142,851 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
135 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use